Search research articles
Contact Us
Filters
Showing results (391-400 of 601) with videos related to
Page
of 61
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
May 4, 2020
Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients
Abdullah S Al Saleh, Harsh V Parmar, Alissa Visram, et al.
Blood
|
September 23, 2008
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping
David C Johnson, Sophie Corthals, Christine Ramos, et al.
British Journal of Haematology
|
November 24, 2011
A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma
Meaghan L Khan, Craig B Reeder, Shaji K Kumar, et al.
Mayo Clinic Proceedings
|
May 10, 2017
Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience
Taxiarchis V Kourelis, Robert A Kyle, David Dingli, et al.
American Journal of Hematology
|
June 25, 2016
Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation
Yi L Hwa, Shaji K Kumar, Morie A Gertz, et al.
American Journal of Hematology
|
March 15, 2016
Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience
Taxiarchis V Kourelis, Francis K Buadi, Shaji K Kumar, et al.
Cancer Medicine
|
October 6, 2020
Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatment
Iuliana Vaxman, Abdullah S Al Saleh, Shaji Kumar, et al.
JCO Oncology Practice
|
May 17, 2022
Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard Care
Surbhi Sidana, Cristine Allmer, Melissa C Larson, et al.
Ejhaem
|
November 29, 2023
Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE-MM2 trial
Paul G Richardson, Thierry Facon, Christopher P Venner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2016
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Meletios A Dimopoulos, Pieter Sonneveld, Nelson Leung, et al.
Page
of 61
Search research articles
Search
Showing results (391-400 of 601) with videos related to
Sort By:
Page
of 61
Clinical Lymphoma, Myeloma & Leukemia
|
May 4, 2020
Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients
Abdullah S Al Saleh, Harsh V Parmar, Alissa Visram, et al.
Blood
|
September 23, 2008
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping
David C Johnson, Sophie Corthals, Christine Ramos, et al.
British Journal of Haematology
|
November 24, 2011
A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma
Meaghan L Khan, Craig B Reeder, Shaji K Kumar, et al.
Mayo Clinic Proceedings
|
May 10, 2017
Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience
Taxiarchis V Kourelis, Robert A Kyle, David Dingli, et al.
American Journal of Hematology
|
June 25, 2016
Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation
Yi L Hwa, Shaji K Kumar, Morie A Gertz, et al.
American Journal of Hematology
|
March 15, 2016
Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience
Taxiarchis V Kourelis, Francis K Buadi, Shaji K Kumar, et al.
Cancer Medicine
|
October 6, 2020
Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatment
Iuliana Vaxman, Abdullah S Al Saleh, Shaji Kumar, et al.
JCO Oncology Practice
|
May 17, 2022
Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard Care
Surbhi Sidana, Cristine Allmer, Melissa C Larson, et al.
Ejhaem
|
November 29, 2023
Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE-MM2 trial
Paul G Richardson, Thierry Facon, Christopher P Venner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2016
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Meletios A Dimopoulos, Pieter Sonneveld, Nelson Leung, et al.
Page
of 61